The cystic fibrosis treatment leader exceeded revenue expectations, but missed slightly on earnings per share.

Shares of Vertex Pharmaceuticals, Inc. were in the spotlight in premarket trading Tuesday as the biotech company received ...

Despite "another impressive quarterly revenue beat" on Tuesday and solid guidance, Vertex stock dipped on light profit.

Gene editing is already being used to treat a handful of rare genetic diseases; however, most therapies involve breaking or ...

Did you see this? Nearly 1 in 10 Americans have asthma. Here's what causes it.

The genetic disorder cystic fibrosis is unique because it can cause both breathing and digestive problems. Some 40,000 people in the U.S. currently have it, "though this is likely an underestimate ...

Despite new medication, cystic fibrosis often leads to permanent lung damage. Working with an international team, researchers ...

The drugmaker is looking to its acute pain drug, Journavx, to drive growth beyond its established line of cystic fibrosis ...

The effect of cystic fibrosis on many organs and the frequent lung infections means that it is mostly diagnosed in childhood. Somehow, for Verônica Stasiak Bednarczuk, that diagnosis did not arrive ...

Despite new medication, cystic fibrosis often leads to permanent lung damage. Working with an international team, researchers from the Technical University of Munich (TUM) have discovered that the ...